Steroids for cardiac surgery: has the story finally ended?

Affiliations

¹ Adult Critical Care Unit, Royal London Hospital, London E1 1BB, UK; Intensive Care Medicine, Queen Mary University of London, London, UK. Electronic address: r.pearse@qmul.ac.uk.
² Toronto General Hospital and University of Toronto, Toronto, ON, Canada; Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada.

Comment

Rupert M Pearse et al. Lancet. 2015.

. 2015 Sep 26;386(10000):1215-1216.

doi: 10.1016/S0140-6736(15)00303-7.

¹ Adult Critical Care Unit, Royal London Hospital, London E1 1BB, UK; Intensive Care Medicine, Queen Mary University of London, London, UK. Electronic address: r.pearse@qmul.ac.uk.
² Toronto General Hospital and University of Toronto, Toronto, ON, Canada; Li Ka Shing Knowledge Institute of St Michael's Hospital, Toronto, ON, Canada.

No abstract available

Comment on

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial.
Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum Á, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S; SIRS Investigators. Whitlock RP, et al. Lancet. 2015 Sep 26;386(10000):1243-1253. doi: 10.1016/S0140-6736(15)00273-1. Lancet. 2015. PMID: 26460660 Clinical Trial.